Literature DB >> 18292813

ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.

Pierre-Damien Denechaud1, Pascale Bossard, Jean-Marc A Lobaccaro, Lesley Millatt, Bart Staels, Jean Girard, Catherine Postic.   

Abstract

The transcription factor carbohydrate-responsive element-binding protein (ChREBP) has emerged as a central regulator of lipid synthesis in liver because it is required for glucose-induced expression of the glycolytic enzyme liver-pyruvate kinase (L-PK) and acts in synergy with SREBP to induce lipogenic genes such as acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). Liver X receptors (LXRs) are also important regulators of the lipogenic pathway, and the recent finding that ChREBP is a direct target of LXRs and that glucose itself can bind and activate LXRs prompted us to study the role of LXRs in the induction of glucose-regulated genes in liver. Using an LXR agonist in wild-type mice, we found that LXR stimulation did not promote ChREBP phosphorylation or nuclear localization in the absence of an increased intrahepatic glucose flux. Furthermore, the induction of ChREBP, L-PK, and ACC by glucose or high-carbohydrate diet was similar in LXRalpha/beta knockout compared with wild-type mice, suggesting that the activation of these genes by glucose occurs by an LXR-independent mechanism. We used fluorescence resonance energy transfer analysis to demonstrate that glucose failed to promote the interaction of LXRalpha/beta with specific cofactors. Finally, siRNA silencing of ChREBP in LXRalpha/beta knockout hepatocytes abrogated glucose-induced expression of L-PK and ACC, further demonstrating the central role of ChREBP in glucose signaling. Taken together, our results demonstrate that glucose is required for ChREBP functional activity and that LXRs are not necessary for the induction of glucose-regulated genes in liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292813      PMCID: PMC2248330          DOI: 10.1172/JCI34314

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase.

Authors:  M M Magaña; S H Koo; H C Towle; T F Osborne
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

2.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver.

Authors:  Tsutomu Kabashima; Takumi Kawaguchi; Brian E Wadzinski; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

4.  A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver.

Authors:  H Yamashita; M Takenoshita; M Sakurai; R K Bruick; W J Henzel; W Shillinglaw; D Arnot; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.

Authors:  M Foretz; C Guichard; P Ferré; F Foufelle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.

Authors:  Sean B Joseph; Bryan A Laffitte; Parthive H Patel; Michael A Watson; Karen E Matsukuma; Robert Walczak; Jon L Collins; Timothy F Osborne; Peter Tontonoz
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

7.  The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression.

Authors:  Angela K Stoeckman; Howard C Towle
Journal:  J Biol Chem       Date:  2002-05-16       Impact factor: 5.157

8.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

9.  Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.

Authors:  Bryan A Laffitte; Lily C Chao; Jing Li; Robert Walczak; Sarah Hummasti; Sean B Joseph; Antonio Castrillo; Damien C Wilpitz; David J Mangelsdorf; Jon L Collins; Enrique Saez; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

10.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

View more
  73 in total

1.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

2.  Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine.

Authors:  Jan Tuckermann; William Bourguet; Susanne Mandrup
Journal:  Mol Endocrinol       Date:  2010-06-02

3.  CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability.

Authors:  Lilia G Noriega; Jérôme N Feige; Carles Canto; Hiroyasu Yamamoto; Jiujiu Yu; Mark A Herman; Chikage Mataki; Barbara B Kahn; Johan Auwerx
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

4.  Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein.

Authors:  Ke Wu; David Cappel; Melissa Martinez; John M Stafford
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

5.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

6.  Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice.

Authors:  Yi Yang; Wang Li; Yang Liu; Yan Li; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

7.  E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver.

Authors:  Qiuwen Lai; Albert Giralt; Cédric Le May; Lianjun Zhang; Bertrand Cariou; Pierre-Damien Denechaud; Lluis Fajas
Journal:  JCI Insight       Date:  2017-05-18

Review 8.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 9.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

10.  Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.

Authors:  Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.